This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovator of Cancer Detection and Treatment - Jeong Hae Choi
Introduction
Jeong Hae Choi, an inventive scientist based in Busan, South Korea, has made significant contributions to the field of biotechnology. His pioneering work focuses primarily on G protein-coupled receptors (GPCRs), which are crucial in various physiological processes and represent important drug targets.
Latest Patents
Choi holds one notable patent titled "G protein coupled receptor protein and use thereof." This invention discloses novel GPCR proteins and the genes encoding them, elucidating various applications in cancer detection and treatment. The patent outlines a method for detecting a cancer marker through the expression of mRNA or protein levels of the GPCR polynucleotide. Additionally, it includes a diagnostic kit for cancer purposes, emphasizing the innovation's potential to impact cancer therapeutics significantly.
Career Highlights
Jeong Hae Choi is affiliated with the Korea Research Institute of Bioscience and Biotechnology, an esteemed institution dedicated to advancing bioscience research. His career is marked by a commitment to developing cutting-edge technologies that harness the capabilities of GPCR proteins for medical applications. His inventions stand at the intersection of science and healthcare, aiming to improve cancer detection methodologies.
Collaborations
Choi collaborates closely with fellow researchers Kyung Sook Chung and Mi Sun Won. Together, they contribute to a collaborative environment that fosters innovation and accelerates the development of biotechnology solutions aimed at addressing significant health challenges, such as cancer.
Conclusion
Jeong Hae Choi's work exemplifies the power of innovation in biotechnology. His patent on GPCR proteins not only enhances our understanding of cancer biology but also opens avenues for novel therapeutic strategies. As ongoing research continues to unfold, Choi's contributions could play a vital role in improving cancer diagnosis and treatment, thereby positively impacting patient outcomes worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile